SunTrust Starts Ekso Bionics (EKSO) at Buy
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
SunTrust Robinson Humphrey initiated coverage on Ekso Bionics (NASDAQ: EKSO) with a Buy rating and a price target of $8.00.
Shares of Ekso Bionics closed at $6.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Researchers to Present Latest Clinical Evidence for Ekso GT Robotic Exoskeleton at ACRM 93rd Annual Conference
- SunTrust Upgrades Vulcan Materials Company (VMC) to Buy
- Graphic Packaging (GPK) PT, Estimates Trimmed at Jefferies Post Q3
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesSunTrust Robinson Humphrey
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!